文献速递真菌感染细菌感染、耐药与抗菌药物

果蝇模型用于研究新兴病原体耳念珠菌的毒力及唑类治疗

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

本研究建立Toll缺陷果蝇感染模型,用10株耳念珠菌及3株白色念珠菌对照,评估毒力与氟康唑/泊沙康唑保护效果。所有耳念珠菌分离株所致死亡率均显著高于白色念珠菌,第7天死亡率>80%对67%(P<0.001-0.005)。果蝇模型可快速可靠低成本研究耳念珠菌致病性及药物活性。

要点

  • Toll缺陷果蝇可快速评估耳念珠菌毒力,7天死亡率>80%。
  • 南美分离株体外生长更快且感染果蝇毒力更强。
  • 氟康唑/泊沙康唑保护效果与分离株体外唑类敏感性一致。

核心结论

  • Toll缺陷果蝇可作为研究耳念珠菌致病性和药物活性的快速、可靠、低成本模型。

研究设计与样本

  • 使用TollI-RXA/Tollr632雌性果蝇感染10株耳念珠菌(CDC抗菌药物耐药库面板)及3株临床白色念珠菌对照。
  • 药物保护实验评估氟康唑或泊沙康唑喂养感染果蝇的生存率、真菌负荷(cfu/g组织)及组织病理学。

主要发现

  • 所有10株耳念珠菌体外生长较慢,但感染果蝇死亡率显著高于白色念珠菌,第7天耳念珠菌感染果蝇>80%死亡,白色念珠菌为67%(P<0.001-0.005)。
  • 不同地理分支耳念珠菌比较:南美分离株体外生长更快且感染果蝇毒力更强;聚集能力对生长和致病性影响极小。
  • 两株耳念珠菌感染果蝇经氟康唑或泊沙康唑喂养后生存保护及真菌负荷降低,与分离株体外唑类敏感性差异一致。
  • 未治疗和抗真菌治疗感染果蝇的生存曲线高度可重复,7天死亡率的变异系数为0.00-0.31。

临床怎么用

  • 果蝇模型可用于耳念珠菌分离株毒力比较和抗真菌药物体内活性初筛。
  • 药物保护效果与体外唑类敏感性一致,支持该模型用于药敏-疗效关联研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Candida auris is an emerging, often MDR, yeast pathogen. Efficient animal models are needed to study its pathogenicity and treatment. Therefore, we developed a C. auris fruit fly infection model. METHODS: TollI-RXA/Tollr632 female flies were infected with 10 different C. auris strains from the CDC Antimicrobial Resistance bank panel. We used three clinical Candida albicans strains as controls. For drug protection assays, fly survival was assessed along with measurement of fungal burden (cfu/g tissue) and histopathology in C. auris-infected flies fed with fluconazole- or posaconazole-containing food. RESULTS: Despite slower in vitro growth, all 10 C. auris isolates caused significantly greater mortality than C. albicans in infected flies, with >80% of C. auris-infected flies dying by day 7 post-infection (versus 67% with C. albicans, P < 0.001-0.005). Comparison of C. auris isolates from different geographical clades revealed more rapid in vitro growth of South American isolates and greater virulence in infected flies, whereas the aggregative capacity of C. auris strains had minimal impact on their growth and pathogenicity. Survival protection and decreased fungal burden of fluconazole- or posaconazole-fed flies infected with two C. auris strains were in line with the isolates' disparate in vitro azole susceptibility. High reproducibility of survival curves for both non-treated and antifungal-treated infected flies was seen, with coefficients of variation of 0.00-0.31 for 7 day mortality. CONCLUSIONS: Toll-deficient flies could provide a fast, reliable and inexpensive model to study pathogenesis and drug activity in C. auris candidiasis.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Wurster S, Bandi A, Beyda ND, et al. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019. PMID: 31225606. doi:10.1093/jac/dkz100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。